目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T4814 | Others Endogenous Metabolite | ||
(R)-5-Oxopyrrolidine-2-carboxylic acid (D-Pyroglutamic acid) 是内源性代谢产物的一种。 | |||
T23631 | 5-HT Receptor | ||
Adatanserin (WY 50324) 是一种混合型 5-HT1A 受体部分激动剂,也是一种 5-HT2A 和 5-HT2C 受体拮抗剂,具有潜在的神经保护活性,可用于研究焦虑和抑郁症。 | |||
T2O2777 | Others Endogenous Metabolite | ||
L-Threonine (threonine) 是人体必需氨基酸,是神经系统的重要氨基酸。L-Threonine 在卟啉和脂肪代谢中也起着重要作用,防止肝脏脂肪堆积。L-Threonine 可用于治疗肠道疾病和消化不良,也可用于缓解焦虑和轻度抑郁。 | |||
T0053 | Histamine Receptor | ||
Hydroxyzine Pamoate (Bobsule) 是一种组胺 H1 受体拮抗剂,可有效治疗慢性荨麻疹、皮炎和组胺介导的瘙痒。它可作为止吐剂和镇静剂,缓解焦虑和紧张。 | |||
T16401 | 5-HT Receptor | ||
Org-12962 是选择性,具有口服活性的 5-HT2C 受体激动剂,pEC50 值为 7.01。 Org-12962 对 5-HT2A 和 5-HT2B 受体也具有很高的作用,pEC50 分别为 6.38 和 6.28。Org-12962 在焦虑大鼠的模型中显示出缓解作用。 | |||
T16836 | FKBP | ||
SAFit2是一种高效、具有选择性的fk506结合蛋白51(FKBP51)抑制剂(Ki:6 nM)。SAFit2能增强AKT2-AS160的结合,参与体内糖皮质激素释放的下游反应,是治疗肥胖、慢性疼痛、抑郁和焦虑的候选化合物。 | |||
T68953 | Reactive Oxygen Species AChR | ||
Arecoline 是一种来自棕榈科植物槟榔的天然生物碱,是有效的烟碱和毒蕈碱乙酰胆碱受体的部分激动剂。Arecoline 具有抗焦虑和抗寄生虫活性,可诱导氧化应激,可用于研究阿尔茨海默病和老年性痴呆。 | |||
T2940 | GABA Receptor | ||
6-Hydroxyflavone (6-HF) 是天然存在的黄酮化合物,具有抗炎作用。它对牛血红蛋白糖基化具有抑制作用。它能激活 AKT、ERK 1/2、JNK 信号通路,有效促进成骨细胞分化。它能抑制 LPS 诱导的 NO 的产生。 | |||
T22591 | GPR 5-HT Receptor Melanin-concentrating Hormone Receptor (MCHR) | ||
ATC 0175 hydrochloride 是一种具有口服活性的黑色素细胞浓缩激素1受体拮抗剂,具有强效性和选择性,ATC 0175 hydrochloride 对MCH1R、MCH2R、MCH1、5-HT2B 受体和5-HT1A 受体 具有亲和力 ,IC50分别为为13.5nM、>10,000 nM、13 nM、9.66 nM 和16.9 nM。ATC 0175 hydrochloride 在动物模型中表现出抗抑郁和抗焦虑作用。ATC0175可用于研究抑郁症和/或焦虑症。 | |||
T1279 | 5-HT Receptor Serotonin Transporter | ||
Vilazodone (SB659746A) 是一种可口服的选择性 5 -羟色胺再摄取抑制剂 (SSRI) 和部分5-HT1A 受体激动剂。它有抗抑郁作用,可用于抑郁症和情绪性疾病的研究。 |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPY-02924 | RGS1 Protein, Human, Recombinant (His) | Human | E. coli | ||
RGS1 (regulator of G-protein signaling 1) has been associated with multiple autoimmune disorders including type I diabetes. RGS1 desensitizes the chemokine receptors CCR7 and CXCR4 that are critical to the localization of T and B cells in lymphoid organs. RGS1 expression may be a prognostic marker for risk stratification and a promising target for the development of a new Multiple myeloma (MM) therapy. The markers in the RGS1 gene might be in linkage disequilibrium with a protective allele that reduces the risk of anxiety and depressive disorders.
|
|||||
TMPY-03991 | DBI Protein, Human, Recombinant (His) | Human | E. coli | ||
The diazepam binding inhibitor (DBI), alternatively known as the acyl-CoA binding protein (ACBP), is involved in multiple biological actions. The polypeptide binds to the peripheral, or mitochondrial, benzodiazepine receptor and facilitates transport of cholesterol to the inner membrane to stimulate steroid synthesis. Through this action, DBI indirectly modulates gamma-aminobutyric acid (GABA)-mediated inhibitory neurotransmission. DBI can be postulated as a candidate gene for psychiatric phenotypes including anxiety, mood, and psychotic disorders. Diazepam Binding Inhibitor (DBI), also called acyl-CoA binding protein (ACBP), is a ubiquitously expressed protein originally identified based on its ability to displace diazepam from its binding site on the GABAA receptor. The mutant allele of the DBI was one of the risk factors for alcohol dependence as for the rs2276596 polymorphism.
|
|||||
TMPY-02648 | PACAP receptor/ADCYAP1R1 Protein, Human, Recombinant (hFc) | Human | HEK293 Cells | ||
Pituitary adenylate cyclase activating polypeptide (PACAP, Adcyap1) activation of PAC1 receptors ( Adcyap1r1) significantly increases excitability of guinea pig cardiac neurons. This modulation of excitability is mediated in part by plasma membrane G protein-dependent activation of adenylyl cyclase and downstream signaling cascades. Studies point to the potential role of the (pituitary) adenylate cyclase activating polypeptide receptor 1 (ADCYAP1R1) gene, which has been implicated in stress response, in posttraumatic stress disorder (PTSD). Pituitary adenylate cyclase-activating polypeptide (PACAP; Adcyap1) and its cognate PAC1 receptor (Adcyap1r1) are expressed in peripheral nociceptive pathways, participate in anxiety-related responses and have been have been linked to posttraumatic stress disorder and other mental health afflictions. Recent studies revealed the role of the PAC1 (ADCYAP1R1) gene variability in vulnerability to posttraumatic stress disorder in women. Due to the relatively high comorbidity of posttraumatic stress disorder and substance use disorder, we hypothesized about possible associations between PAC1 gene and problematic alcohol use.
|
|||||
TMPY-01618 | GLO1 Protein, Mouse, Recombinant (His) | Mouse | E. coli | ||
Lactoylglutathione lyase, also known as Methylglyoxalase, Aldoketomutase, Glyoxalase I, Ketone-aldehyde mutase, S-D-lactoylglutathione methylglyoxal lyase and GLO1, is a member of the glyoxalase I family. GLO1 / Glyoxalase I is a ubiquitous cellular defense enzyme involved in the detoxification of methylglyoxal, a cytotoxic byproduct of glycolysis. Accumulative evidence suggests an important role of GLO1 expression in protection against methylglyoxal-dependent protein adduction and cellular damage associated with diabetes, cancer, and chronological aging. GLO1 / Glyoxalase I has been implicated in anxiety-like behavior in mice and in multiple psychiatric diseases in humans. GLO1 / Glyoxalase I catalyzes the conversion of hemimercaptal, formed from methylglyoxal and glutathione, to S-lactoylglutathione. GLO1 / Glyoxalase I exists in three separable isoforms which originate from two alleles in the genome. These correspond to two homodimers and one heterodimer composed of two subunits showing different electrophoretic properties. GLO1 upregulation may play a functional role in glycolytic adaptations of cancer cells.
|